alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 99-1915

CONRAD N. FREUND,

Plaintiff - Appellee,

versus

KENNETH MITAN,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of Virginia, at Roanoke. James C. Turk, District Judge.

(CA-98-107-7)

Submitted: November 20, 2000 Decided: January 5, 2001

Before WILKINS and KING, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished per curiam opinion.

Daniel C. Summerlin, WOODS, ROGERS & HAZELGROVE, P.L.C., Roanoke,

Virginia, for Appellant. Michaux Raine, III, RAINE & PERDUE,

P.L.C., Rocky Mount, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

Local Rule 36(c).
2

PER CURIAM:

Kenneth Mitan appeals the district court’s order denying his

motion to dismiss for lack of jurisdiction and entering a civil

judgment against him for $147,056.67. On appeal, Mitan only alleges that the district court erred in finding that it had personal

jurisdiction over him; he raises no issues related to the amount or

propriety of the judgment itself. We have reviewed the record and

the district court’s opinion and find no reversible error.

Accordingly, we affirm on the reasoning of the district court.

Freund v. Mitan, No. CA-98-107-7 (W.D. Va. June 7, 1999) (denying

motion to dismiss for reasons as stated from the bench). We dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED
Exhibit 32.1



18 U.S. Section 1350 CERTIFICATIONS







In connection with the Annual Report of Intra-Asia Entertainment Corporation (the  “Company” ) on Form 10-KSB for the fiscal year ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James A. Reskin, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



Date: July 26, 2004



/s/ James A. Reskin

James A. Reskin, Chief Executive Officer



Date: July 26, 2004



/s/ James A. Reskin

James A. Reskin, Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF ALLIED HOLDINGS, INC. FOR THE NINE MONTH ENDED
SEPTEMBER 30, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<EXCHANGE-RATE>                                      1
<CASH>                                          11,527
<SECURITIES>                                         0
<RECEIVABLES>                                   27,200
<ALLOWANCES>                                         0
<INVENTORY>                                      3,875
<CURRENT-ASSETS>                                55,888
<PP&E>                                         132,977
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 218,598
<CURRENT-LIABILITIES>                           52,434
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      54,673
<TOTAL-LIABILITY-AND-EQUITY>                   218,598
<SALES>                                        288,174
<TOTAL-REVENUES>                               288,174
<CGS>                                          276,132
<TOTAL-COSTS>                                  276,132
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,143
<INCOME-PRETAX>                                  4,348
<INCOME-TAX>                                     1,826
<INCOME-CONTINUING>                              2,522
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                   (935)
<CHANGES>                                            0
<NET-INCOME>                                     1,587
<EPS-PRIMARY>                                      .21
<EPS-DILUTED>                                      .21
        

</TABLE>
Hassanh Bey WRIGHT, aka Hassanh Bay Wright, petitioner, v. UNITED STATES.

No. 18-5238.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; Precursors of AD/ADHD.                    

*Date:*                         June 6, 2022.                    

*Time:*                         4:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Kimberly Firth, Ph.D., National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7702,                         *firthkm@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: May 10, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-10422 Filed 5-13-22; 8:45 am]

BILLING CODE 4140-01-P
EXHIBIT
32
 
 
 STATEMENT
REQUIRED BY 18 U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO SECTION 906
 OF
THE SARBANES-OXLEY ACT OF 2002
 
 
 In
connection with the Annual Report on Form 10-K of Uonlive Corporation (f/k/a
China World Trade Corporation) (the "Company") for the year ended December
31, 2008, as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), I, Tsun Sin Man Samuel, Chief Executive Officer, and Hui
Chi Kit, Chief Financial Officer of the Company, individually certify
that:
 
 ·
              the
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and
 
 ·
              information
      contained in the Report fairly presents, in all material respects, the
      financial condition and results of operations of the Company on the dates
      and for the periods presented.
 
 
 /s/  Tsun
      Sin Man Samuel
                Tsun
      Sin Man Samuel
                Chief
      Executive Officer
                
                Dated:  March
      30, 2009
                
                
                /s/
      Hui Chi Kit
                Hui
      Chi Kit
                Chief
      Financial Officer
                
                Dated:  March
      30, 2009
 
 
 A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Uonlive Corporation (f/k/a China World
Trade Corporation) and will be retained by Uonlive Corporation and furnished to
the Securities and Exchange Commission or its staff upon request.
Fourth Court of Appeals

San Antonio, Texas

June 21, 2018

No. 04-18-00339-CV

IN RE Abelardo G. GONZALEZ

Original Mandamus Proceeding1

ORDER

Sitting: Rebeca C. Martinez, Justice

Patricia O. Alvarez, Justice

Irene Rios, Justice

On May 30, 2018, this court denied relator’s petition for writ of mandamus, in which 

relator complained of the trial court’s refusal to rule on his pending motion to recuse the 

Honorable Victor Villarreal. On June 14, 2018, relator filed a motion for rehearing. The next 

day, this court received a copy of an Order Granting Motion to Recuse, which was signed by the 

Honorable Sid L. Harle, Presiding Judge, Fourth Administrative Judicial Region.

Because the relief originally requested by relator has now been granted, we DENY AS 

MOOT his motion for rehearing.

It is so ORDERED on June 21, 2018.

_________________________________

Rebeca C. Martinez, Justice

 

1 This proceeding arises out of Cause No. 2017 FLI 001815 C3, styled In the Interest of M.A.G. and Z.A.G., 

Children, pending in the County Court at Law No 2, Webb County, Texas, the Honorable Victor Villarreal

presiding.
IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 21st day of June, 2018.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the quarterly report on Form 10-Q of Bedford Property Investors, Inc. (the Company) for the quarter ended June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Hanh Kihara, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), that:



1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:   August 9, 2004

/s/ Hanh Kihara

Hanh Kihara

Chief Financial Officer





A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Page 29380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10275]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Interchangeable Virtual Instruments Foundation, 
Inc.

    Notice is hereby given that, on March 25, 2022, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Interchangeable Virtual 
Instruments Foundation, Inc. (``IVI Foundation'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, ThinkRF, Kanata, 
Ontario, CANADA, has withdrawn as a party to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and IVI Foundation intends to file 
additional written notifications disclosing all changes in membership.
    On May 29, 2001, IVI Foundation filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on July 30, 2001 (66 FR 39336).
    The last notification was filed with the Department on April 2, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 15, 2021 (86 FR 19901).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-10275 Filed 5-12-22; 8:45 am]
BILLING CODE 4410-11-P
[Federal Register Volume 87, Number 91 (Wednesday, May 11, 2022)]
[Notices]
[Page 28837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10123]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel; Nucleic Acid Sequencing Technologies.
    Date: June 1, 2022.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 300, Bethesda, MD 
20892, (Virtual Meeting).
    Contact Person: Keith McKenney, Ph.D., Scientific Review 
Officer, National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 300, Bethesda, MD 
20892, (301) 435-1580, <a href="/cdn-cgi/l/email-protection#3a5759515f54545f43517a575b535614545352145d554c"><span class="__cf_email__" data-cfemail="7f121c141a11111a06143f121e16135111161751181009">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: May 6, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-10123 Filed 5-10-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Pages 29420-29421]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10258]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-94874; File No. SR-MIAX-2022-16]


Self-Regulatory Organizations; Miami International Securities 
Exchange, LLC; Notice of Withdrawal of Proposed Rule Change To Amend 
the MIAX Fee Schedule To Adopt a Tiered-Pricing Structure for 
Additional Limited Service MIAX Express Interface Ports

May 9, 2022.
    On April 1, 2022, Miami International Securities Exchange, LLC 
(``MIAX'' or

[[Page 29421]]

``Exchange'') filed with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 19(b)(1) of the Securities 
Exchange Act of 1934 (``Act''),\1\ and Rule 19b-4 thereunder,\2\ a 
proposed rule change to amend the Exchange's Fee Schedule to adopt a 
tiered-pricing structure for additional limited service express 
interface ports.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A). A proposed rule change may take 
effect upon filing with the Commission if it is designated by the 
exchange as ``establishing or changing a due, fee, or other charge 
imposed by the self-regulatory organization on any person, whether 
or not the person is a member of the self-regulatory organization.'' 
15 U.S.C. 78s(b)(3)(A)(ii).
    \4\ 15 U.S.C. 78s(b)(3)(C).
    \5\ 15 U.S.C. 78s(b)(2)(B).
    \6\ See Securities Exchange Act Release No. 94720 (April 14, 
2022), 87 FR 23586.
---------------------------------------------------------------------------

    The proposed rule change was immediately effective upon filing with 
the Commission pursuant to Section 19(b)(3)(A) of the Act.\3\ On April 
20, 2022, the proposed rule change was published for comment in the 
Federal Register and, pursuant to Section 19(b)(3)(C) of the Act,\4\ 
the Commission: (1) Temporarily suspended the proposed rule change; and 
(2) instituted proceedings under Section 19(b)(2)(B) of the Act \5\ to 
determine whether to approve or disapprove the proposed rule change.\6\ 
On May 2, 2022, the Exchange withdrew the proposed rule change (SR-
MIAX-2022-16).

    For the Commission, by the Division of Trading and Markets, 
pursuant to delegated authority.\7\
---------------------------------------------------------------------------

    \7\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2022-10258 Filed 5-12-22; 8:45 am]
BILLING CODE 8011-01-P
Exhibit 10.12


 


 





The Joint Corp.


Executive Short-Term Incentive Plan (STIP)


 


Plan Overview


 


The Joint Corp. (“the Company”) Executive Short-Term
Incentive Plan (“Executive STIP”) is an annual bonus plan. The STIP pool earned for each year will be determined based
upon the achievement of the Company’s Target EBITDA for that year.


 


Eligibility: The CEO and CFO of the Company are eligible
to participate in the Executive STIP. Participants must be actively employed by the Company on the date of payout in order to receive
an award under the Executive STIP. The following are the eligible percentages of base salary:


 


	CEO	 	50%
	CFO	 	40%




 


Proration: For those participants whose employment with the
Company starts during mid-year, their participation in the plan shall be prorated based on the number of days employed during that
calendar year divided by 365 days.


 


Award: 100% of each individual Executive STIP award is a function of achieving
the Target EBITDA (defined below). The percentage of achievement of that metric will be the same as the percentage of funding (between
zero and 100%) of the maximum bonus pool.


 


STIP awards are expected to be paid following approval by the Compensation
Committee of the Board of Directors (the “Compensation Committee”) and completion of the Company’s annual audit.
Executive STIP awards will be paid in cash by no later than March 15th of the following year.


 


EBITDA Bonus Accelerator: If total EBITDA achieved exceeds
the Target EBITDA for the year after 100% funding of the STIP Pool discussed above, the Company will fund an additional 25% into
the bonus pool (up to a maximum of 125% of the participants’ target STIP) to be allocated to participants on a pro-rata basis
based on their respective eligibility. The STIP Pool plus this additional 25% Bonus Accelerator will represent the Adjusted STIP
Pool to be awarded.


 


Plan Description


 


Target EBITDA: In connection with the annual budgeting process,
the Company will establish an annual budget with corresponding EBITDA that must be approved by the Board of Directors of the Company.


 


EBITDA Definition: The Company shall prepare a budget on
a consistent basis from year to year and apply a consistent definition of EBITDA. The company currently defines EBITDA as net income
(loss) before interest expense, income taxes, depreciation, and amortization expenses.
Joseph COONEY, petitioner, v. BARRY SCHOOL OF LAW, aka Dwayne O. Andreas School of Law.

No. 17-1690.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.